These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 319900)
21. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update. Khoury-Collado F; St Clair C; Abu-Rustum NR Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924 [TBL] [Abstract][Full Text] [Related]
22. Tumor size in endometrial cancer. Schink JC; Rademaker AW; Miller DS; Lurain JR Cancer; 1991 Jun; 67(11):2791-4. PubMed ID: 2025843 [TBL] [Abstract][Full Text] [Related]
23. The case against Wertheim's hysterectomy in endometrial carcinoma. de Mûelenaere GF J Obstet Gynaecol Br Commonw; 1973 Aug; 80(8):728-34. PubMed ID: 4725951 [No Abstract] [Full Text] [Related]
24. Management and results of endometrial carcinoma treated at Instituto Português de Oncologia de Francisco Gentil. Tavares MA; Patricio MB; Vilhena M; Da Silva JN Cancer; 1977 Feb; 39(2):675-80. PubMed ID: 402190 [TBL] [Abstract][Full Text] [Related]
25. A contemporary review of uterine cancer management. Carter J Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):517-24. PubMed ID: 23829412 [TBL] [Abstract][Full Text] [Related]
26. [Histomorphologic prognostic factors in stage I endometrial cancers]. Köhler U; Bilek K; Rosenkranz M Zentralbl Gynakol; 1987; 109(20):1245-54. PubMed ID: 3425025 [TBL] [Abstract][Full Text] [Related]
27. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant therapy of uterine clear cell carcinoma: a review. Xu Y; Hanna RK; Elshaikh MA Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183 [TBL] [Abstract][Full Text] [Related]
29. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System. Siesto G; Romano F; Fiamengo B; Vitobello D J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824 [TBL] [Abstract][Full Text] [Related]
30. Endometrial carcinoma: the role of irradiation. Underwood PB; Taylor PT Clin Obstet Gynaecol; 1986 Dec; 13(4):767-87. PubMed ID: 3791830 [TBL] [Abstract][Full Text] [Related]
31. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis. Isrow D; Burmeister C; Hanna RK; Elshaikh MA Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535 [TBL] [Abstract][Full Text] [Related]
32. Stage I endometrial adenocarcinoma: treatment results in 835 patients. Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429 [TBL] [Abstract][Full Text] [Related]
33. Treatment variables in the management of endometrial cancer. Figge DC; Otto PM; Tamimi HK; Greer BE Am J Obstet Gynecol; 1983 Jul; 146(5):495-500. PubMed ID: 6859175 [TBL] [Abstract][Full Text] [Related]
34. Treatment failure sites according to irradiation technique and histology in patients with endometrial cancer. Landgren RD; Fletcher GH; Gallager HS; Declos L; Wharton JT Cancer; 1977 Jul; 40(1):131-5. PubMed ID: 880546 [TBL] [Abstract][Full Text] [Related]